Reference | Cohort birth period | Exclusions (details in text) | Geographical cohort | Antenatal steroids | Postnatal surfactant | Age at survival | Proportion of live births surviving for each week of gestation (%) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 | 24 | 25 | 26 | 27 | |||||||||||
EPICure4 | Mar 95–Dec 95 | No | Yes | Yes (64%) | Yes (87%) | dis | 11 | 27 | 47 | ||||||
Cartlidge5 | 1993–1994 | Yes | Yes | Yes2-150 | Yes2-150 | neo | 5 | 26 | 59 | 69 | 74 | ||||
Tin6 | 1991–1994 | Yes | Yes | Yes2-150 | Yes2-150 | 1 y | 2 | 17 | 35 | 53 | 70 | ||||
Kilpatrick7 | 1990–1994 | Yes | No | Yes (83%) | Yes (95%) | dis | 49 | 78 | 83 | ||||||
Kramer8 | Jul 89–Dec 93 | No | No | Yes (18%) | Yes (100%) | 6 m | 19 | 48 | 25 | 75 | 71 | ||||
Lefebvre9 | 1987–1992 | Yes | No | Yes2-150 | Yes2-150 | dis | 0 | 23 | 50 | 64 | 78 | ||||
Allen10 | May 88–Sep 91 | No | No | No | Yes2-150 | 6 m | 17 | 56 | 79 | ||||||
Gray11 | Jun 88–May 90 | Yes | No | Yes2-150 | No | dis | 57 | 68 | 83 | 89 | |||||
Tin6 | 1987–1990 | Yes | Yes | Yes2-150 | Yes2-150 | 1 y | 18 | 17 | 33 | 45 | 64 | ||||
Synnes12 | 1983–1989 | No | No | No | No | dis | 16 | 43 | 55 | 63 | 77 | ||||
EC Study13 | 1986 | Yes | Yes | No | No | dis | 17 | 13 | 27 | 50 | 36 | ||||
EC Study13 | 1986 | Yes | Yes | No | No | dis | 0 | 0 | 40 | 18 | 50 | ||||
Nicholl14 | 1983–1989 | Yes | No | No | No | dis | 8 | 43 | 59 | 65 | 85 | ||||
EC Study13 | 1985 | Yes | Yes | No | No | dis | 0 | 5 | 19 | 48 | 48 | ||||
Tin6 | 1983–1986 | Yes | Yes | No | No | 1 y | 3 | 10 | 21 | 42 | 59 | ||||
EC Study13 | 1983 | Yes | Yes | No | No | dis | 0 | 0 | 14 | 37 | 52 | ||||
Combined estimate | 10 | 27 | 44 | 55 | 67 | ||||||||||
(95% CI) | (8–12) | (24–30) | (41–47) | (52–58) | (64–70) |
↵2-150 Percentage not specified.
neo, neonatal period (28 days); 1 y, 1 year of age; dis, discharge from hospital; 6 m, 6 months of age.